Head-to-head · free
Genmab vs Intuitive Surgical, Inc.
GMAB vs ISRG — return on capital, cash generation, margins and balance sheet side by side.
GMAB
3 / 5
measures where GMAB leads
ISRG
2 / 5
measures where ISRG leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | GMAB | ISRG · FY2025 |
|---|---|---|
| Revenue | — | $10.1B |
| Net income | — | $2.9B |
| Revenue growth (yearly, multi-year) | — | 67.1% |
| Free cash flow | — | — |
| Free cash flow margin | — | — |
| Net cash / (debt) | — | — |
| ROIC | 10.1% | 14.8% |
| Return on equity | 17.5% | 16.7% |
| Gross margin | 93.6% | 66.0% |
| Operating margin | 33.6% | 29.3% |
| Net debt / EBITDA | 3.13x | -0.93x |
Figures are as reported by each company; latest fiscal year shown.
Where Intuitive Surgical, Inc.'s cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free